Schütz C - Search Results

1

CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells.

Bruns H, Bessell C, Varela JC, Haupt C, Fang J, Pasemann S, Mackensen A, Oelke M, Schneck JP, Schütz C. Bruns H, et al. Among authors: schutz c. Clin Cancer Res. 2015 May 1;21(9):2075-83. doi: 10.1158/1078-0432.CCR-14-2696. Epub 2015 Jan 15. Clin Cancer Res. 2015. PMID: 25593301 Free PMC article.

2

Killer artificial antigen presenting cells (KaAPC) for efficient in vitro depletion of human antigen-specific T cells.

Schütz C, Fleck M, Schneck JP, Oelke M. Schütz C, et al. J Vis Exp. 2014 Aug 11;(90):e51859. doi: 10.3791/51859. J Vis Exp. 2014. PMID: 25145915 Free PMC article.

3

Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy.

Perica K, Bieler JG, Schütz C, Varela JC, Douglass J, Skora A, Chiu YL, Oelke M, Kinzler K, Zhou S, Vogelstein B, Schneck JP. Perica K, et al. Among authors: schutz c. ACS Nano. 2015 Jul 28;9(7):6861-71. doi: 10.1021/acsnano.5b02829. Epub 2015 Jul 14. ACS Nano. 2015. PMID: 26171764 Free PMC article.

4

Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells.

Schütz C, Varela JC, Perica K, Haupt C, Oelke M, Schneck JP. Schütz C, et al. Oncotarget. 2016 Oct 18;7(42):68503-68512. doi: 10.18632/oncotarget.11785. Oncotarget. 2016. PMID: 27602488 Free PMC article.

5

Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

Schütz C, Fleck M, Mackensen A, Zoso A, Halbritter D, Schneck JP, Oelke M. Schütz C, et al. Blood. 2008 Apr 1;111(7):3546-52. doi: 10.1182/blood-2007-09-113522. Epub 2007 Dec 20. Blood. 2008. PMID: 18096763 Free PMC article.

6

Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.

Schütz C, Oelke M, Schneck JP, Mackensen A, Fleck M. Schütz C, et al. Immunotherapy. 2010 Jul;2(4):539-50. doi: 10.2217/imt.10.26. Immunotherapy. 2010. PMID: 20636007 Free PMC article. Review.

7

MHC-Ig induces memory T cell formation in vivo and inhibits tumour growth.

Schütz C, Zoso A, Peng S, Bennett JD, Schneck JP, Oelke M. Schütz C, et al. Immun Inflamm Dis. 2014 Nov;2(3):181-92. doi: 10.1002/iid3.35. Epub 2014 Nov 11. Immun Inflamm Dis. 2014. PMID: 25505552 Free PMC article.

8

Soluble MHC class I complexes for targeted immunotherapy.

Schappert A, Schneck JP, Suarez L, Oelke M, Schütz C. Schappert A, et al. Among authors: schutz c. Life Sci. 2018 Sep 15;209:255-258. doi: 10.1016/j.lfs.2018.08.023. Epub 2018 Aug 10. Life Sci. 2018. PMID: 30102903 Free PMC article. Review.

9

Correction: Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells.

Schütz C, Varela JC, Perica K, Haupt C, Oelke M, Schneck JP. Schütz C, et al. Oncotarget. 2018 Aug 17;9(64):32401. doi: 10.18632/oncotarget.26018. eCollection 2018 Aug 17. Oncotarget. 2018. PMID: 30190796 Free PMC article.

10

The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.

Mougiakakos D, Bach C, Böttcher M, Beier F, Röhner L, Stoll A, Rehli M, Gebhard C, Lischer C, Eberhardt M, Vera J, Büttner-Herold M, Bitterer K, Balzer H, Leffler M, Jitschin S, Hundemer M, Awwad MHS, Busch M, Stenger S, Völkl S, Schütz C, Krönke J, Mackensen A, Bruns H. Mougiakakos D, et al. Among authors: schutz c. Cancer Immunol Res. 2021 Mar;9(3):265-278. doi: 10.1158/2326-6066.CIR-20-0555. Epub 2021 Feb 9. Cancer Immunol Res. 2021. PMID: 33563611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

373 results

Search Page

Filters